MedX announces the completion of first sale in New Zealand

NewsGuard 100/100 Score

MedX Limited, the manufacturer and global distributor of MedX®-branded medical exercise and fitness equipment and a subsidiary of WellTek Incorporated (OTC Bulletin Board: WTKN), today announced the completion of its first sale in New Zealand, succeeding the sale of 227 MedX exercise and medical machines to customers in a diverse list of countries, including Australia, Germany, India, Scotland, South Korea, Spain and Switzerland. The recently sold MedX equipment will be used in various medical rehabilitation and fitness facilities throughout the aforementioned countries.  

"The completion of this sale helps to further reinforce the fact that our global expansion strategy is working," stated Larry Evans, MedX President.  "WellTek has been leveraging the well-trusted MedX brand throughout the United States in key growth niche markets to drive MedX sales in the domestic health, fitness and wellness industry.  However, our recent sales of equipment to a growing base of international customers is part of our greater strategy to extend the reach of our brand and materially increase our penetration of the industry on a universal basis."

Incorporated into every MedX product is decades of experience and millions of dollars of independent, university-based research. Its products achieve training efficiency through resistance curves matched to tested and proven strength profiles.

SOURCE WellTek Incorporated

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Regular late-life exercise has a beneficial impact on DNA damage and telomere dysfunction